Our roundup is up! Amazon adds Amazon Connect Health agentic AI for provider workflows to their roster. Amazon’s multiplicity ...

Wasn’t this GLP-1 compounding tussle supposed to be over by now? FDA has sent warning letters to 30 telehealth companies warning them about their continued sale of compounded GLP-1 drugs. The warning ...

In yesterday’s update to pending record layoffs at Oracle, affecting Oracle Health, new reporting mentioned the breakdown of Oracle’s expansion agreement with OpenAI in building out a leased data ...

Grow Therapy’s $150 million Series D brings their total funding to $328 million and their valuation to $3 billion. Their ...

Oracle had good news yesterday. Its Q3 2026 closed with strong earnings per share ($1.79 adjusted EPS versus expected $1.70), GAAP adjusted EPS at $1.27, and revenue topping $17.19 billion versus the ...

The pennydrop was as early as last September in a filing, according to Mr. Ford. It was estimated in the filing that $1.6 ...

She had been head of Optum for a year, replaced by Patrick Conway, the CEO of Optum Rx. In 24 years in the UHG universe, Ms. Cianfrocco had held senior positions in UHG’s major divisions including ...

Teladoc formally responds to the Blue Orca Capital research report [TTA 25 Feb]. Their letter (PDF) via its legal counsel (King & Spalding) yesterday refutes Blue Orca’s allegations in a report on ...

There’s a small uptick and some optimism in the air for US digital health deals after all. After a 2024 that realistically was a ‘down round’ or Back To 2019, 2025 is picking its way through the New ...

Hims & Hers expands to Ireland, France, and Germany, and adds to UK. Announced yesterday, the ambitious strategic acquisition of Zava, a similar online direct to consumer provider of telemedicine ...